Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter

Thrombosis and Haemostasis

Volumn 100, Issue 1, 2008, Pages 167-168

  Verso, Melina ^a   Agnelli, Giancarlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 5; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; WARFARIN;

ARM; BLEEDING; CANCER PATIENT; CENTRAL VENOUS CATHETER; DEEP VEIN THROMBOSIS; HUMAN; LETTER; PHLEBOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; THROMBOCYTOPENIA;

ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; PATIENT SELECTION; RISK ASSESSMENT; VENOUS THROMBOSIS;

EID: 46749137848     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-03-0199     Document Type: Letter

References (15)

1. Bern HM, Lokich JJ, Wallach SR, et al. Very low dose of warfarin can prevent thrombosis in central venous catheters: a randomized, prospective trial. Ann Inter Med 1990; 112: 423-428.
2. Monreal M, Alastrue A, Rull M, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-253.
3. Verso M, Agnelli G, Bertoglio S, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheters: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062.
4. Karthaus M, Kretzschmar A, Kröning H, et al. A Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006; 17: 289-296.
5. Couban S, Goodyear M, Burnell M, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069.
6. Young AM, Begum G, Billingham LJ. WARP-a multicentre, prospective, randomized controlled trial of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). Ann ASCO Meet 2005; Abstr 8004.
7. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. Chest 2004; 126: 338S-400S.
8. Chaukiyal P, Nautiyal A, Radhakrishnan S, et al. Thromboprophylaxis in cancer patietns with central venous catheters. A systematic review and metanalysis. Thromb Haemost 2008; 99: 38-43.
9. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003, 21: 3665-3675.
10. Agnelli G, Verso M. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. J Thromb Haemost 2006; 4: 14-15.
11. Agnelli G, Verso M. Therapy insight: venous catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol 2006; 3: 214-222.
12. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and the risk of venous thrombosis. J Am Med Assoc 2005; 293: 715-722.
13. Lee AYY, Levine MN, Butler G, et al. Incidence, risk factors and outcomes of catheter-related thrombo sis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-1408.
14. Dentali F, Gianni M, Agnelli G, et al. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis. J Thromb Haemost 2008, 6: 70-75.
15. Verso M, Agnelli G, Kamphuisen P, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheterin cancer patients. Intern Emerg Med 2008; epub ahead of print.